About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Michigan | 573 Studies

Clinical Trials Prostate CancerMichigan

Prostate Cancer Clinical Trials in Michigan

Find 573 clinical trials for prostate cancer near Michigan. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Michigan

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 321-340 of 573 trials

CompletedImaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer RecurrenceA prospective, Phase 3, multi center, single-arm, imaging study investigating the safety and diagnostic performance of rhPSMA 7.3 (18F) Positron Emission Tomography (PET) ligand…NCT04186845·Birmingham, Alabama and 27 others TerminatedOpen-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesThe purpose of the Study is to select a dose and assess the safety and tolerability of INCB057643 as a monotherapy (Part 1 and Part 2) and in combination with standard-of-care…NCT02711137·Birmingham, Alabama and 17 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedStudy of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100This study will evaluate the effect of cabozantinib compared to prednisone on overall survival in men with previously treated metastatic castration-resistant prostate cancer with…NCT01605227·Birmingham, Alabama and 263 others

CompletedPhase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced CancersThis is a phase 1/1b open-label, multicenter, dose-selection study of ciforadenant, an oral small molecule targeting the adenosine-A2A receptor on T-lymphocytes and other cells of…NCT02655822·Tucson, Arizona and 19 others

RecruitingUrine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE TrialThis clinical trial tests how well a urine prostate cancer screening test, My Prostate Score 2 (MPS2), integrated with magnetic resonance imaging (MRI) works for early detection…NCT07526545·Ann Arbor, Michigan

CompletedBI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)The overall aim of the trial is to investigate the safety and anti-tumour activity of an experimental drug BI 836845 taken together with the prostate cancer drug, enzalutamide…NCT02204072·Detroit, Michigan and 26 others

CompletedA Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsThis is a Phase 1, multiple dose, ascending-dose escalation study and expansion study designed to define a maximum tolerated dose and/or recommended dose of XmAb22841 monotherapy…NCT03849469·Encinitas, California and 27 others

RecruitingStudy of Oral MRT-2359 With Apalutamide in Prostate CancerThis Phase 2, open-label, multicenter study is conducted in patients with castration-resistant prostate cancer.NCT07745361·Los Angeles, California and 13 others

TerminatedA Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid TumorsThis study is an open-label, multi-center, dose-escalation, dose expansion study in adult subjects with advanced solid tumors.NCT05084859·Tucson, Arizona and 19 others

Active not recruitingSafety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)The purpose of this study is to assess enzalutamide plus leuprolide in patients with high-risk nonmetastatic prostate cancer progressing after radical prostatectomy or…NCT02319837·Birmingham, Alabama and 254 others

CompletedStudy to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.The main purpose of this first human study with CC-115 is to assess the safety and action of a new class of experimental drug (dual DNA-PK and TOR kinase inhibitors) in patients…NCT01353625·Los Angeles, California and 16 others

CompletedRadiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells and shrink tumors. Androgens can cause the growth of prostate cancer cells.NCT00936390·Birmingham, Alabama and 517 others

Active not recruitingZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate CancerThis phase II trial investigates how well ZEN-3694, enzalutamide, and pembrolizumab work in treating patients with castration-resistant prostate cancer that has spread to other…NCT04471974·San Francisco, California and 2 others

CompletedI-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).This clinical trial was done to show whether a radioactive drug (I-131-1095) that binds to prostate-specific membrane antigen (PSMA) is useful in treating metastatic prostate…NCT03939689·Duarte, California and 26 others

Active not recruitingA Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate CancerThe purpose of this study is to: a) establish the recommended phase 2 dose (RP2D) and to evaluate the antitumor activity and safety of niraparib combination therapies…NCT03431350·Tucson, Arizona and 49 others

CompletedCabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate CancerThis partially randomized phase I/II trial studies cabazitaxel with or without carboplatin in treating patients with previously treated prostate cancer that has spread to other…NCT01505868·Detroit, Michigan and 1 other

TerminatedYM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone TherapyThe purpose of this study is to determine if patients who take YM598 in addition to mitoxantrone and prednisone (standard therapy) experience improvement in the pain associated…NCT00048659·Anchorage, Alaska and 52 others

CompletedAndrogen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate CancerThis phase II trial studies how well androgen deprivation therapy and vorinostat followed by radical prostatectomy works in treating patients with prostate cancer that has not…NCT00589472·Los Angeles, California and 14 others

CompletedGenetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot StudyThis trial studies the genetic analysis of blood and tissue samples from patients with cancer that has spread to other anatomic sites (advanced) or is no longer responding to…NCT03707574·Fort Lauderdale, Florida and 143 others

CompletedLighting Intervention for Cancer-related FatigueFatigue is a major problem for cancer patients, and one that can persist long after treatment ends.NCT04827446·Ann Arbor, Michigan

PreviousPage 17 of 29Next

Other Conditions in Michigan

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma